Farallon Capital Management’s PhenomeX Inc. Common Stock CELL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-787,327
Closed -$14.3M 339
2021
Q4
$14.3M Buy
+787,327
New +$17M 0.07% 109

Other funds holding CELL

Farallon Capital Management's CELL Position: Q1 2022 in Review

Farallon Capital Management sold out of PhenomeX Inc. Common Stock (CELL) in Q1 2022, closing a stake of 787,327 shares — an estimated $14.3M sold.

Farallon Capital Management first reported a position in CELL in Q4 2021 and held it in 1 quarter. The position peaked at $14.3M in Q4 2021. 130 funds tracked by Wall St. Rank hold CELL as of Q1 2022.

  • Farallon Capital Management reported no remaining PhenomeX Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Farallon Capital Management sold 787,327 PhenomeX Inc. Common Stock shares in Q1 2022, an estimated $14.3M.
  • Farallon Capital Management first reported a position in PhenomeX Inc. Common Stock in Q4 2021 and held it in 1 quarter.
  • Farallon Capital Management's PhenomeX Inc. Common Stock position peaked at $14.3M in Q4 2021.
  • 130 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q1 2022.

Based on Farallon Capital Management's 13F filing for Q1 2022, filed 16 May 2022.